Clinical trial
Trial of Intranasal Insulin in Children and Young Adults at Risk of Type 1…
NCT00336674 · Melbourne Health, Other · Completed
Key facts
| NCT number | NCT00336674 |
|---|---|
| Title | Trial of Intranasal Insulin in Children and Young Adults at Risk of Type 1 Diabetes |
| Official title | A Randomised, Double-blind, Placebo-controlled Trial of Intranasal Insulin (440 IU) in Children and Young Adults at Risk of Type 1 Diabetes: Intranasal Insulin Trial II |
| Acronym | INITII |
| Lead sponsor | Melbourne Health, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Type 1 Diabetes |
| Intervention type | Biological, Other |
| Interventions | Intranasal insulin, Placebo |
| Enrollment | 110 |
| Start date | Dec 1, 2006 |
| Primary completion | Nov 13, 2019 |
| Completion | Nov 13, 2019 |
| First posted | Jun 14, 2006 |
| Last update posted | Oct 8, 2020 |
| Countries | Australia, New Zealand |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: